Drugs / Sterofundin
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT00135473 | Apr 2003 → Sep 2005 | infectious disease with sepsis | SepNet - Critical Care Trials Group | Completed | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT02950974 | Nov 2014 → Mar 2015 | — | Ramathibodi Hospital | Completed | No outcome recorded |
| — | NCT02520804 | Nov 2014 → Jun 2017 | acute kidney injury | Mahidol University | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03249298 Comparator | Jan → Dec 2017 | — | University Medical Centre Ljubljana | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sterofundin | “Sterofundin” NCT03249298 ↗ |
| Known as | Ringer lactate solution | “Sterofundin® (Ringer lactate solution)” NCT00135473 ↗ |